Season 1, Episode 12: The Future of Immuno-Oncology with Mark Frohlich

Michael Pietrack sits down with Mark Frohlich, a Harvard-trained medical Oncologist and CEO of Indapta Therapeutics! He discusses his experience in the Pharmaceutical industry as a pioneer in Immuno-Oncology. He emphasizes the importance of understanding the immune system and the integration of…

May 27^th • 19 mins listen

Breaking Down Checkpoint Inhibitors

ONS member Virginia Bayer, BSN, RN, CCRP, research nurse supervisor at MD Anderson Cancer Center, joins ONS’s Barbara Lubejko, MS, RN, to discuss checkpoint inhibitors, their impact on patient care, what oncology nurses need to know about immunotherapies, and much more.

Mar 14^th • 51 mins listen